The study, sponsored by University Hospital, Rouen, aims to address neurodevelopmental difficulties in preterm infants, particularly focusing on language development and its impact on reading skills. With a significant prevalence of cognitive and language disorders in this population, successful outcomes could lead to the establishment of early intervention protocols that may enhance educational performance and reduce long-term healthcare costs. The market for pediatric neurodevelopmental interventions is growing, with increasing awareness and demand for effective therapies. However, challenges in patient enrollment have led to the termination of the trial, which may hinder the validation of the proposed hypothesis and limit immediate commercial prospects.